Thymic Cancer
12 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| PT-112 in Subjects With Thymoma and Thymic Carcinoma (NCT05104736) | National Cancer Institute (NCI) | 2022-04-06 |
| Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic Carcinoma (NCT04417660) | National Cancer Institute (NCI) | 2020-12-26 |
| Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors (NCT04234113) | SOTIO Biotech AG | 2019-06-13 |
| Cardiac MRI Biomarker Testing (GCC 1618) (NCT02688166) | University of Maryland, Baltimore | 2018-02-01 |
| Cognitive Testing of Tobacco Use Measurement Items for Administration With Cancer Patients and Survivors (NCT02233842) | National Cancer Institute (NCI) | 2014-09-01 |
| Genetic Evaluation of Families With Endocrine Cancers (NCT01794676) | Jersey Shore University Medical Center | 2013-03-01 |
| A Study to Test the Safety and Efficacy of Erlotinib Plus Bevacizumab to Treat Advanced Thymoma and Thymic Cancer (NCT00369889) | Indiana University | 2006-08-01 |
Track Thymic Cancer automatically
Every clearance here is in the API, with alerts when new ones post.